Diamond Hill Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Diamond Hill Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Hold	92,212	–	–	0.01%	174
2026 Q1	$1.37M	Hold	92,212	–	–	0.01%	170
2025 Q4	$1.47M	Sell	92,212 -23,991	-21%	-$340K	0.01%	175
2025 Q3	$1.28M	Hold	116,203	–	–	0.01%	177
2025 Q2	$984K	Buy	116,203 +46,104	+66%	+$370K	﹤0.01%	174
2025 Q1	$564K	Hold	70,099	–	–	﹤0.01%	172
2024 Q4	$629K	Hold	70,099	–	–	﹤0.01%	174
2024 Q3	$514K	Hold	70,099	–	–	﹤0.01%	170
2024 Q2	$400K	Hold	70,099	–	–	﹤0.01%	168
2024 Q1	$351K	Buy	70,099 +15,020	+27%	+$102K	﹤0.01%	162
2023 Q4	$495K	Buy	55,079 +26,505	+93%	+$218K	﹤0.01%	155
2023 Q3	$222K	Hold	28,574	–	–	﹤0.01%	164
2023 Q2	$277K	Hold	28,574	–	–	﹤0.01%	162
2023 Q1	$313K	Hold	28,574	–	–	﹤0.01%	161
2022 Q4	$123K	Hold	28,574	–	–	﹤0.01%	169
2022 Q3	$215K	Hold	28,574	–	–	﹤0.01%	167
2022 Q2	$287K	Hold	28,574	–	–	﹤0.01%	161
2022 Q1	$354K	Buy	28,574 +9,390	+49%	+$145K	﹤0.01%	161
2021 Q4	$439K	Buy	19,184 +715	+4%	+$16.9K	﹤0.01%	158
2021 Q3	$409K	Hold	18,469	–	–	﹤0.01%	155
2021 Q2	$239K	Buy	+18,469	New	+$235K	﹤0.01%	153

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diamond Hill Capital Management's AUPH Position: Q2 2026 in Review

Diamond Hill Capital Management held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 92,212 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #174.

Diamond Hill Capital Management first reported a position in AUPH in Q2 2021 and has held it in 21 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Diamond Hill Capital Management held 92,212 shares of Aurinia Pharmaceuticals worth $1.56M as of Q2 2026.
Diamond Hill Capital Management left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
Aurinia Pharmaceuticals made up 0.01% of Diamond Hill Capital Management's portfolio in Q2 2026, its #174 holding.
Diamond Hill Capital Management first reported a position in Aurinia Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Diamond Hill Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.